ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,975Medicare Part D Prescriptions Filled, Including Refills

Rank: 153 out of 6969

$671K Total Retail Price of All Prescriptions

Rank: 317 out of 6969

907 Patients Receiving at Least One Drug in Part D
81%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

7% of this provider’s 907 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 12,436 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

19% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$45 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

17 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
METFORMIN HCL 841 673 1 7
OMEPRAZOLE 801 582 2 6
SIMVASTATIN 604 514 3 1
LISINOPRIL 580 496 4 2
AMLODIPINE BESYLATE 435 404 5 4
METOPROLOL SUCCINATE 381 335 6 22
LOSARTAN POTASSIUM 327 276 7 12
HYDROCHLOROTHIAZIDE 311 287 8 8
LEVOTHYROXINE SODIUM 293 263 9 5
BENAZEPRIL HCL 287 248 10 18
ALENDRONATE SODIUM 279 266 11 14
CARVEDILOL 275 239 12 25
METOPROLOL TARTRATE 265 221 13 13
FUROSEMIDE 240 202 14 10
PRAVASTATIN SODIUM 234 195 15 19
GLIPIZIDE 231 200 16 21
LISINOPRIL-HYDROCHLOROTHIAZIDE 222 212 17 28
LOVASTATIN 219 205 18 15
TRAMADOL HCL 215 205 19 27
WARFARIN SODIUM 204 125 20 20
TAMSULOSIN HCL 191 182 21 23
PAROXETINE HCL 181 155 22 65
GABAPENTIN 179 141 23 17
RANITIDINE HCL 177 152 24 46
HYDROCODONE-ACETAMINOPHEN 170 125 S3 25 3
FINASTERIDE 170 149 25 80
AMLODIPINE BESYLATE-BENAZEPRIL 163 128 27 91
GLYBURIDE-METFORMIN HCL 162 110 R 28 92
CHLORTHALIDONE 159 123 29 152
ATENOLOL 147 134 30 9
SERTRALINE HCL 146 119 31 38
ISOSORBIDE MONONITRATE ER 143 115 32 81
IBUPROFEN 140 92 33 29
ATORVASTATIN CALCIUM 138 119 34 11
MELOXICAM 131 119 35 36
TERAZOSIN HCL 127 127 36 49
PROAIR HFA 124 93 37 33
ZOLPIDEM TARTRATE 119 94 38 16
LANTUS 118 104 39 50
INSULIN SYRINGE 112 88 40 60
ADVAIR DISKUS 110 89 41 45
FLUOXETINE HCL 109 73 42 43
GLIPIZIDE-METFORMIN 107 79 43 362
DONEPEZIL HCL 103 103 44 32
ACTOS 93 68 45 61
DICLOFENAC SODIUM 88 79 46 78
FLUTICASONE PROPIONATE 87 57 47 24
JANUVIA 78 47 48 41
NAPROXEN 77 38 49 62
CLOPIDOGREL 75 67 50 48
PLAVIX 74 67 51 68
TRIAMCINOLONE ACETONIDE 73 63 52 55
SULFAMETHOXAZOLE-TRIMETHOPRIM 73 64 52 114
AVODART 71 68 54 108
GLIMEPIRIDE 70 55 55 44
CITALOPRAM HBR 65 58 56 34
HYDROXYCHLOROQUINE SULFATE 65 42 56 341
MECLIZINE HCL 63 29 58 100
PEN NEEDLE 62 45 59 196
DIOVAN 60 35 60 26
HUMALOG MIX 75-25 58 44 61 367
VENTOLIN HFA 54 46 62 125
AMITRIPTYLINE HCL 53 49 R 63 87
LEVEMIR 52 46 64 232
POLYETHYLENE GLYCOL 3350 51 47 65 127
DOXAZOSIN MESYLATE 51 51 65 74
LEVEMIR FLEXPEN 51 33 65 253
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 1, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.